Position history for Woodline Partners LP's holdings in CYTOKINETICS INC
Woodline Partners LP holds 1.6M shares of CYTK (CYTOKINETICS INC), worth $104.7M as of 2025-Q4. The position was increased (++0.0% shares). CYTK represents 0.4% of Woodline Partners LP's portfolio.
Current Value
$104.7M
Current Shares
1.6M
Total Value Change
+$94M
Total Shares Change
+1.5M
Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 1.6M |
+0.0% |
| $104.7M |
| 0.4% |
| $61.37 |
36 |
| 2025-Q3 | Increased | 1.6M | +676.1% | $90.6M | 0.4% | $53.89 | 58 |
| 2025-Q2 | Unchanged | 212,303 | 0.0% | $7M | 0.0% | $33.16 | 0 |
| 2025-Q1 | Increased | 212,303 | +68.2% | $8.5M | 0.1% | $43.19 | 41 |
| 2024-Q4 | Decreased | 126,201 | -2.2% | $5.9M | 0.0% | $47.15 | 0 |
| 2024-Q3 | Decreased | 129,035 | -34.9% | $6.8M | 0.1% | $52.34 | 0 |
| 2024-Q2 | New | 198,181 | - | $10.7M | 0.1% | $54.18 | 46 |